Oric Pharmaceuticals (ORIC) Earnings Date & Reports
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ORIC is expected to report earnings to rise 5.00% to -35 cents per share on August 06
Q2'26
Est.
$-0.36
Q1'26
Missed
by $0.02
Q4'25
Beat
by $0.07
Q3'25
Beat
by $0.07
Q2'25
Missed
by $0.03
The last earnings report on May 04 showed earnings per share of -34 cents, missing the estimate of -31 cents. With 306.35K shares outstanding, the current market capitalization sits at 819.86M.